CytoDyn Inc says data from leronlimab trial is a step forward, demonstrating the drug's potential for inhibiting liver fibrosis

“Though numerous drugs have been evaluated in clinical trials, there have been no approvals by the US Food and Drug Administration for...

Related Keywords

Nader Pourhassan ,Drug Administration ,Cytodyn Inc ,Fast Track Designation ,